MTOR and cancer: Nevertheless, as we found that impact of PTX and ABT-737 on these pro-apoptotic proteins was less effective in resistant clones than in progenitors (Fig. 3d), targeting PI3K/Akt/mTOR might be a more efficient option against PTX-resistant cancer than apoptotic induction.